| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Agreement Among Different Scales for Causality Assessment in Drug-Induced Liver Injury
|
Das, Saibal
|
|
2017
|
38 |
3 |
p. 211-218
|
artikel
|
| 2 |
A Review of Switching Biologic Agents in the Treatment of Moderate-to-Severe Plaque Psoriasis
|
Hu, Yifan
|
|
2017
|
38 |
3 |
p. 191-199
|
artikel
|
| 3 |
Author Correction to: Prevalence of Use and Cost of Biological Drugs for Cancer Treatment: A 5-Year Picture from Southern Italy
|
Lucchesi, Simona
|
|
2017
|
38 |
3 |
p. 279-285
|
artikel
|
| 4 |
Discontinuation of Efavirenz in Paediatric Patients: Why do Children Switch?
|
Wynberg, Elke
|
|
2017
|
38 |
3 |
p. 231-238
|
artikel
|
| 5 |
Ledipasvir–Sofosbuvir for 8 Weeks in Non-Cirrhotic Patients with Previously Untreated Genotype 1 HCV Infection ± HIV-1 Co-Infection
|
Isakov, Vasily
|
|
2017
|
38 |
3 |
p. 239-247
|
artikel
|
| 6 |
Ledipasvir–Sofosbuvir for 8 Weeks in Non-Cirrhotic Patients with Previously Untreated Genotype 1 HCV Infection ± HIV-1 Co-Infection
|
Isakov, Vasily
|
|
|
38 |
3 |
p. 239-247
|
artikel
|
| 7 |
Lithium Toxicity in Older Adults: a Systematic Review of Case Reports
|
Sun, Meng
|
|
2017
|
38 |
3 |
p. 201-209
|
artikel
|
| 8 |
Pharmacokinetics and Safety of Ingenol Disoxate Gel Administered Under Maximum-Use Conditions to Patients With Actinic Keratosis
|
Lain, Edward
|
|
2017
|
38 |
3 |
p. 249-257
|
artikel
|
| 9 |
Pharmacokinetics of Oral and Intravenous Paracetamol (Acetaminophen) When Co-Administered with Intravenous Morphine in Healthy Adult Subjects
|
Raffa, Robert B.
|
|
2017
|
38 |
3 |
p. 259-268
|
artikel
|
| 10 |
Prevalence of Use and Cost of Biological Drugs for Cancer Treatment: A 5-Year Picture from Southern Italy
|
Lucchesi, Simona
|
|
|
38 |
3 |
p. 269-278
|
artikel
|
| 11 |
Prevalence of Use and Cost of Biological Drugs for Cancer Treatment: A 5-Year Picture from Southern Italy
|
Lucchesi, Simona
|
|
2017
|
38 |
3 |
p. 269-278
|
artikel
|
| 12 |
Surveillance on The Safety and Efficacy of Ambrisentan (Volibris Tablet 2.5 mg) in Patients with Pulmonary Arterial Hypertension in Real Clinical Practice: Post-marketing Surveillance (Interim Analysis Report)
|
Takahashi, Tomohiko
|
|
2017
|
38 |
3 |
p. 219-229
|
artikel
|
Tijdschrift beschrijving